Young Women’s Eggs: Elite and Ordinary
By Elizabeth Reis, Biopolitical Times guest contributor
| 09. 15. 2011
My college-age daughter can earn $50,000-$100,000 just for being smart, beautiful, tall, and a Harvard student. Yes, going to Harvard could actually pay off, even sooner than we might have imagined. $100,000 would go a long way toward paying her tuition and fees, a fact that she has pointed out to me many times. And all she would have to do is “donate” her eggs to an infertile couple willing to pay.
“Donate” is quite a misnomer. Young women are getting paid handsomely, though there is outrageous discrepancy between what are considered “elite” and more ordinary eggs. At the University of Oregon, where I teach, advertisements frequently appear in the student newspaper offering only $5000 for my students’ eggs. Still, many are tempted. I worry that young women are being unfairly lured by these exorbitant sums (even $5000 is a lot to a college student at a public university) to sign on to something that we can’t really be sure is safe in the long run.
One danger is ovarian hyperstimulation syndrome (OHSS), a potentially harmful condition caused by the...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...